Cargando…

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure

Risk stratification is an important element of management in patients with heart failure (HF). We aimed to determine factors associated with predicting outcomes in end-stage HF patients listed for heart transplantation (HT), with particular emphasis placed on pentraxin-3 (PXT-3). In addition, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczurek-Wasilewicz, Wioletta, Skrzypek, Michał, Romuk, Ewa, Gąsior, Mariusz, Szyguła-Jurkiewicz, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099900/ https://www.ncbi.nlm.nih.gov/pubmed/35566693 http://dx.doi.org/10.3390/jcm11092567

Ejemplares similares

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure †
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Prognostic scales in advanced heart failure
por: Szczurek, Wioletta, et al.
Publicado: (2018)

Obesity in patients with end-stage heart failure
por: Król, Bogumiła, et al.
Publicado: (2018)

Oxidative Stress Markers in Hypertrophic Cardiomyopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
por: Siedlecki, Łukasz, et al.
Publicado: (2017)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Mechanical circulatory support in heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2016)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy
por: Dyrbuś, Maciej, et al.
Publicado: (2020)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
por: Romuk, Ewa, et al.
Publicado: (2020)

Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2021)

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease
por: Osadnik, Tadeusz, et al.
Publicado: (2016)

Temporary Trends Concerning the Extent and Efficacy of Atrial Fibrillation Ablation Using Radiofrequency Energy in a Polish Single-Center Experience
por: Myrda, Krzysztof, et al.
Publicado: (2022)

Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality
por: Valente, Maria João, et al.
Publicado: (2019)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
por: Pyka, Łukasz, et al.
Publicado: (2017)

Regulation of pentraxin-3 by antioxidants
por: Hill, A. L., et al.
Publicado: (2009)

Pentraxins in Complement Activation and Regulation
por: Ma, Ying Jie, et al.
Publicado: (2018)

Regulation of the Complement System by Pentraxins
por: Haapasalo, Karita, et al.
Publicado: (2019)

Pentraxin 3 in Cardiovascular Disease
por: Ristagno, Giuseppe, et al.
Publicado: (2019)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Electromagnetic Fields Modify Redox Balance in the Rat Gastrointestinal Tract
por: Sieroń, Karolina, et al.
Publicado: (2021)

Pentraxin-3 Predicts Long-Term Cardiac Events in Patients with Chronic Heart Failure
por: Liu, Haibo, et al.
Publicado: (2015)

Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation
por: Cheng, Xingxing S., et al.
Publicado: (2017)

The concentration of interleukin-33 in heart failure with reduced ejection fraction
por: Anna Segiet, Oliwia, et al.
Publicado: (2019)

Dilemmas in end-stage heart failure
por: Chen-Scarabelli, Carol, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_14lhji6op43nqgnrf8tbb1fvq0